Advanced Biomed is trading at $8.13 (-5.20%) in pre-market, with no reliable August 14, 2026 company-specific announcement or overnight catalyst identified.

  • Recent coverage concerns an earlier 120-case feasibility study announced February 13, not a new event.
  • The decline does not clearly track broader markets: S&P 500 futures are up 0.04% and Nasdaq futures 0.11%.
  • Profit-taking after the prior session’s 12.89% gain may be a factor, but remains unconfirmed.